Thanks George , good point on the equity, could be adjusted to...

Thanks George , good point on the equity, could be adjusted to suit

Hey Meph personally in my deal the PRV would be hands of, they would be taking the rights to the drug for DMD only in whichever of the 50% global route they took

The PRV would be reserved as the teaser for another partnering deal with one of our new indications, doesn't necessarily have to be an outright cash sale although the value would indirectly added into any partnering talks for a new indication to make the deal look more attractive

See how we go